Jonathan Brett

Jonathan Brett

Auto-generated profile, based on publicly available information

Jonathan Brett

Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health UNSW Sydney Sydney Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Australian Prescriber
Verified
Journal Article
Open access
JBJonathan Brett
Jonathan Brett
BMBridin Murnion
Bridin Murnion
There are well-recognised harms from long-term use of benzodiazepines. These include dependency, cognitive decline and falls. It is important to prevent and recognise benzodiazepine dependence. A thorough risk assessment guides optimal management and the necessity for referral. The management of dependence involves either gradual benzodiazepine withdrawal or maintenance treatment. Prescribing interventions, substitution, psychotherapies and pharmacotherapies can all contribute. Unless the patient is elderly, it is helpful to switch to a long-acting benzodiazepine in both withdrawal and maintenance therapy. The dose should be gradually reduced over weeks to lower the risk of seizures. Harms from drugs such as zopiclone and zolpidem are less well characterised. Dependence is managed in the same manner as benzodiazepine dependence.

6 August 2018 in BMJ Quality & Safety
Verified
Journal Article
Open access
PDF file
TBTim Badgery-Parker
Tim Badgery-Parker
SPSallie-Anne Pearson
Sallie-Anne Pearson
KCKelsey Chalmers
Kelsey Chalmers
JBJonathan Brett
Jonathan Brett
ISIan A Scott
Ian A Scott
AEAdam G Elshaug
Adam G Elshaug
Objective To examine 27 low-value procedures, as defined by international recommendations, in New South Wales public hospitals. Design Analysis of admitted patient data for financial years 2010–2011 to 2016–2017. Main outcome measures Number and proportion of episodes identified as low value by two definitions (narrower and broader), associated costs and bed-days, and variation between hospitals in financial year 2016–2017; trends in numbers of low-value episodes from 2010–2011 to 2016–2017. Results For 27 procedures in 2016–2017, we identified 5079 (narrower definition) to 8855 (broader definition) episodes involving low-value care (11.00%–19.18% of all 46 169 episodes involving these services). These episodes were associated with total inpatient costs of $A49.9 million (narrower) to $A99.3 million (broader), which was 7.4% (narrower) to 14.7% (broader) of the total $A674.6 million costs for all episodes involving these procedures in 2016–2017, and involved 14 348 (narrower) to 29 705 (broader) bed-days. Half the procedures accounted for less than 2% of all low-value episodes identified; three of these had no low-value episodes in 2016–2017. The proportion of low-value care varied widely between hospitals. Of the 14 procedures accounting for most low-value care, seven showed decreasing trends from 2010–2011 to 2016–2017, while three (colonoscopy for constipation, endoscopy for dyspepsia, sentinel lymph node biopsy for melanoma in situ) showed increasing trends. Conclusions Low-value care in this Australian public hospital setting is not common for most of the measured procedures, but colonoscopy for constipation, endoscopy for dyspepsia and sentinel lymph node biopys for melanoma in situ require further investigation and action to reverse increasing trends. The variation between procedures and hospitals may imply different drivers and potential remedies.

31 July 2017 in Australian & New Zealand Journal of Psychiatry
Verified
Journal Article
Open access
JBJonathan Brett
Jonathan Brett
EKEmily A Karanges
Emily A Karanges
BDBenjamin Daniels
Benjamin Daniels
NBNicholas A Buckley
Nicholas A Buckley
CSCarl R. Schneider
Carl R. Schneider
SPSallie-Anne Pearson
Sallie-Anne Pearson
Objective: To examine changes in annual patterns of psychotropic medication use in Australia from 2007 to 2015. Methods: We used a 10% sample of individual-level nationwide dispensing claims for concessional beneficiaries dispensed psychotropic medications (stratified by class, subclass) to investigate annual trends and changes in the incidence and prevalence of use, median annual duration of exposure, proportion of people with single psychotropic dispensing and median defined daily doses per person dispensed each medicine per year. Results: Over the study period, there was a 26.1% decrease in the incidence and a 2.6% increase in the prevalence of all psychotropic medicine use. We observed a decrease in the annual incidence and prevalence of antidepressants (11.6% and 16.8%, respectively) but increases in the median annual duration of exposure (7.4%). Amitriptyline had the highest proportion of single dispensings of all antidepressants throughout the study period (26.5% in 2015) and defined daily doses per person dispensed each medicine per year increased by 20% for antidepressants overall. Benzodiazepine use decreased across all measures over the study period apart from long-term use (exposure for >240 days of the year), which in 2015 was 23.6% of those dispensed a benzodiazepine. We observed a relative increase in the incidence and prevalence of antipsychotic use (14.2% and 26.8%, respectively), and haloperidol had the highest proportion of single dispensings of any antipsychotic throughout the study period (47.5% in 2015). We observed a relative increase in the incidence and prevalence of attention-deficit hyperactivity disorder medication use of 114.0% and 101.8%, respectively, over the study period. Conclusion: Increasing doses and treatment durations of antidepressants warrants further investigation due to concerns about overuse. Single dispensings of amitriptyline and haloperidol may indicate off-label use and long-term use of benzodiazepines remains problematic. Despite increases in attention-deficit hyperactivity disorder medication use, prevalence of use is still much lower than the estimated prevalence of attention-deficit hyperactivity disorder in the adult population.

5 March 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
KCKelsey Chalmers
Kelsey Chalmers
TBTim Badgery-Parker
Tim Badgery-Parker
DPDr Sallie Pearson
Dr Sallie Pearson
JBJonathan Brett
Jonathan Brett
ISIan A. Scott
Ian A. Scott
AEAdam G. Elshaug
Adam G. Elshaug
Low-value health care refers to interventions where the risk of harm or costs exceeds the likely benefit for a patient. We aimed to develop indicators of low-value care, based on selected Choosing Wisely (CW) recommendations, applicable to routinely collected, hospital claims data. We assessed 824 recommendations from the United States, Canada, Australia and the United Kingdom CW lists regarding their capacity to be measured in administrative hospital admissions datasets. We selected recommendations if they met the following criteria: the service occurred in the hospital setting (observable in setting); a claim recorded the use of the service (record of service); the appropriate/inappropriate use of the service could be mapped to information within the hospital claim (indication); and the service is consistently recorded in the claims (consistent documentation). We identified 17 recommendations (15 services) as measurable. We then developed low-value care indicators for two hospital datasets based on the selected recommendations, previously published indicators, and clinical input.

27 December 2017 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
EKEmily A. Karanges
Emily A. Karanges
NBNicholas A. Buckley
Nicholas A. Buckley
JBJonathan Brett
Jonathan Brett
BBBianca Blanch
Bianca Blanch
MLMelisa Litchfield
Melisa Litchfield
DPDr Sallie Pearson
Dr Sallie Pearson

12 February 2018 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
JBJonathan Brett
Jonathan Brett
DMDonovan T. Maust
Donovan T. Maust
ZBZach Bouck
Zach Bouck
RIRosalinda V. Ignacio
Rosalinda V. Ignacio
GMGraham Mecredy
Graham Mecredy
SPSallie A. Pearson
Sallie A. Pearson